Replies to post #171450 on Biotech Values

[ronpopeil]

I agree. I think ABBV/ENTA will be very competitive. Looking forward their results coming out soon. So far, I think GILD v. ENTA/ABBV are somewhat close with their data. Both drugs work very well. ENTA/ABBV should get a decent size of this very large market.